BridgeBio Oncology Therapeutics, Inc (BBOT)

Last Closing Price: 1.80 (2026-11-18)

Beginning Cash (Quarterly)

Beginning Cash: The amount of cash reported by the company on its previous statement.

BridgeBio Oncology Therapeutics, Inc (BBOT) had Beginning Cash of $373.82M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-34.18M
--
--
$37.49M
$-37.49M
$3.31M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-34.18M
$-37.49M
$-37.30M
80.19M
80.19M
$-0.43
$-0.43
Balance Sheet Financials
$208.33M
$0.81M
$137.90M
$346.22M
$51.03M
--
$1.81M
$52.84M
$293.39M
$293.39M
$293.39M
80.23M
Cash Flow Statement Financials
$-108.64M
$-189.34M
$0.77M
Beginning Cash
$373.82M
$76.61M
$-297.21M
$15.84M
--
--
Fundamental Metrics & Ratios
4.08
--
--
--
--
--
--
--
--
--
--
$-108.73M
--
--
--
--
--
--
--
-11.65%
-11.65%
-9.87%
-11.65%
$3.66
$-1.36
$-1.35